Inventor
BEVILACQUA MICHAEL P
US19 patents
⚠️ This page may combine multiple inventors who share the name “BEVILACQUA MICHAEL P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMICROBE INC
5 patentsUS9446090B2Sep 20, 2016
Compositions and uses of antimicrobial materials with tissue-compatible properties
AMICROBE INC13 citations82
US11298401B2Apr 12, 2022
Compositions and uses of antimicrobial materials with tissue-compatible properties
AMICROBE INC2 citations71
US11285189B2Mar 29, 2022
Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety
AMICROBE INC4 citations64
US12016898B2Jun 25, 2024
Compositions and uses of antimicrobial materials with tissue-compatible properties
AMICROBE INC0 citations60
US12268722B2Apr 8, 2025
Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety
AMICROBE INC0 citations53
UNIV CALIFORNIA
4 patentsUS5527785AJun 18, 1996
Selectin receptor modulating compositions
UNIV CALIFORNIA81 citations95
US5827837AOct 27, 1998
Polyanion anti-inflammatory agents
UNIV CALIFORNIA75 citations92
US10448634B2Oct 22, 2019
Composition with high antimicrobial activity and low toxicity
UNIV CALIFORNIA5 citations81
US9017730B2Apr 28, 2015
Compositions and uses of materials with high antimicrobial activity and low toxicity
UNIV CALIFORNIA13 citations81
BRIGHAM & WOMENS HOSPITAL
4 patentsUS5081034AJan 14, 1992
Cloned genes which encode elam-1
BRIGHAM & WOMENS HOSPITAL105 citations94
US5403713AApr 4, 1995
Antibodies specific for ELAM-1 and the use thereof
BRIGHAM & WOMENS HOSPITAL56 citations93
US6166179ADec 26, 2000
Inducible endothelial surface protein mediating melanoma cell adhesion, antibodies, and uses
BRIGHAM & WOMENS HOSPITAL7 citations69
US5821340AOct 13, 1998
Inducible endothelial surface protein mediating lymphoid and tumor cell adhesion: antibodies and uses
BRIGHAM & WOMENS HOSPITAL3 citations58
AMGEN INC
3 patentsUS6294170B1Sep 25, 2001
Composition and method for treating inflammatory diseases
AMGEN INC122 citations98
US6096728AAug 1, 2000
Composition and method for treating inflammatory diseases
AMGEN INC322 citations98
US6733753B2May 11, 2004
Composition and method for treating inflammatory diseases
AMGEN INC73 citations97
SOURCE PRECISION MEDICINE INC
2 patentsUS6964850B2Nov 15, 2005
Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
SOURCE PRECISION MEDICINE INC142 citations97
US6692916B2Feb 17, 2004
Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
SOURCE PRECISION MEDICINE INC164 citations97